Treatment of metabolic acidosis in small clinical trials appears to be safe. We caution the reader about side effects associated with some of these treatments that differ in patients with CKD Stages 4 and 5 compared with patients on dialysis. The use of cinacalcet has been associated with hyper...
Patients aged 20 years and older were randomly assigned 2:1 to treatment with dapagliflozin 5 to 10 mg per day (n = 120), in addition to integrated CKD care, or integrated CKD care alone (n = 60). The patients had a mean age of 67.5 years in the dapagliflozin group, and 71.4 in ...
Treatment of metabolic acidosis in small clinical trials appears to be safe. We caution the reader about side effects associated with some of these treatments that differ in patients with CKD Stages 4 and 5 compared with patients on dialysis. The use of cinacalcet has been associated with hyper...
Antiglycemic treatment should be implemented with metformin and SGLT2-inhibitors as first-line therapy, and glomerular filtration rate thresholds must be respected for both drugs. The risk of hypoglycemia is increased with worsening kidney function. Statins are indicated for up to stage 5 CKD. When...
Generally, these disturbances become clinically manifest with CKD stages 4-5 (GFR < 30 mL/min/1.73 m²). Patients with tubulointerstitial disease, cystic diseases, nephrotic syndrome, and other conditions associated with “positive” symptoms (eg, polyuria, hematuria, edema) are more likely to ...
Phosphate Metabolism in CKD Stages 3–5: Dietary and Pharmacological Control When compared to the available information for patients on dialysis (CKD stage 5D), data on the epidemiology and appropriate treatment of calcium and phosphate metabolism in the predialysis stages of chronic kidney disease (...
1.Clinical Experience on Treatment ofCKDWith Aconite Composing Prescriptions by Yang Hong Tao杨洪涛运用附子组方治疗慢性肾脏病临床经验 2.The researches about the diagnosis and treatment ofCKDare important and difficult and hot for the Integrative Chinese and Western medicine Clinic study.中西医结合研究...
OPTA: Optimal treatment of anaemia in patients with chronic kidney disease (CKD) In the early stages of CKD, anaemia is non-symptomatic. Patients adapt to a certain level and to further declining haemoglobin (Hb) levels. The fact that m... W. H. Hörl,Y. Vanrenterghem,P. Aljama,.....
The stages of CKD are classified as follows [5] : Stage 1: Kidney damage with normal or increased GFR (> 90 mL/min/1.73 m2) Stage 2: Mild reduction in GFR (60-89 mL/min/1.73 m2) Stage 3a: Moderate reduction in GFR (45-59 mL/min/1.73 m2) Stage 3b: Moderate reduction in ...
被引量: 5发表: 2017年 The Impact of Medical Nutrition Intervention on the Management of Hyperphosphatemia in Hemodialysis Patients with Stage 5 Chronic Kidney Disease: A Case Series The treatment and interdisciplinary management of patients with chronic kidney disease (CKD) continue to improve long-...